All In Biotech

Drug Trial Radar · NCT07297667

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

A Phase I Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Participants With Selected Relapsed/Refractory GPNMB-Expressing Solid Tumours

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Aug 30, 2026

Primary completion

Dec 1, 2028

Study completion Sep 1, 2033

Sponsor

Lead sponsor
Canadian Cancer Trials GroupResearch network
Sponsor type
Research network
Collaborators
University of Calgary; Canadian Institutes of Health Research (CIHR); BioCanRx
First posted
Dec 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Only enrolling in Canada. The purpose of this study is to identify the highest dose of GCAR1, a chimeric antigen receptor (CAR-T) cell therapy, that can be tolerated without causing very severe side effects, and to see what effects GCAR1 has on selected cancers

Conditions

  • Alveolar Soft Part Sarcoma
  • Renal Cell Carcinoma
  • Triple Negative Breast Cancer

Interventions

  • FludarabineDrug

    Assigned at enrollment

  • CyclophosphamideDrug

    Assigned at enrollment

  • GCAR1Biological

    Dose escalation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To determine the recommended phase II dose (RP2D), defined as the next lower dose below the maximum administered dose, of GPNMB directed CAR T cell therapyTime frame: 3 years

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Arthur J.E. Child Comprehensive Cancer Centre

    Calgary, Alberta, Canada · Recruiting

  • Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada · Recruiting

  • University Health Network

    Toronto, Ontario, Canada · Recruiting

  • The Research Institute of the McGill University

    Montreal, Quebec, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.